How effective is Sprycel for Chronic Myeloid Leukaemia? (a real world drug study)
Summary:
Overall ratings: 4.6/5 Long term ratings: 5/5
This is a phase IV clinical study of how effective Sprycel (dasatinib) is for Chronic myeloid leukaemia and for what kind of people. The study is created by eHealthMe from 7 Sprycel users and is updated continuously.
What is Sprycel?
Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.
What is Chronic myeloid leukaemia?
Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood) is found to be associated with 321 drugs and 442 conditions by eHealthMe. Check the latest studies of Chronic myeloid leukaemia.
7 people are studied for taking Sprycel in Chronic myeloid leukaemia
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Sprycel effectiveness for Chronic myeloid leukaemia (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 1
- very high: 5
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 0
- very high: 2
Gender of people who take Sprycel for Chronic myeloid leukaemia *:
- female: 57.14 %
- male: 42.86 %
Age of people who take Sprycel for Chronic myeloid leukaemia *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 14.29 %
- 30-39: 0.0 %
- 40-49: 42.86 %
- 50-59: 14.29 %
- 60+: 28.57 %
Who find Sprycel more effective for Chronic Myeloid Leukaemia?
Gender of people who take Sprycel for Chronic myeloid leukaemia *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Sprycel for Chronic myeloid leukaemia *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 50.0 %
- 50-59: 16.67 %
- 60+: 33.33 %
* Approximation only. Some reports may have incomplete information.
Do you take Sprycel?
- You can start a phase IV clinical trial to monitor Sprycel safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Bacalja J, Ulamec M, Rako D, ?oipi ?, Miji? A, Kru?lin B, "Adrenal gland hemangiosarcoma in a patient with chronic myeloid leukaemia", Int J Case Rep Med, 2013 Jan .
- Bacalja J, Ulamec M, Rako D, ?oipi ?, Miji? A, Kru?lin B, "Adrenal gland hemangiosarcoma in a patient with chronic myeloid leukaemia", Int J Case Rep Med, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Sprycel (29,788 reports)
Treatments, associated drugs and conditions:
- Chronic myeloid leukaemia (90,350 reports)
How the study uses the data?
The study is based on dasatinib (the active ingredients of Sprycel) and Sprycel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Qsymia and Fatigue for Women aged 60+ - 4 seconds ago
- Qsymia and Exhaustion, Fatigue, Lethargy, Tiredness, Weariness for Women aged 60+ - 4 seconds ago
- Qsymia and Weariness for Women aged 60+ - 5 seconds ago
- Qsymia and Tiredness for Women aged 60+ - 5 seconds ago
- Qsymia and Exhaustion for Women aged 60+ - 5 seconds ago
- Drug interactions of Strattera and Albuterol - 5 seconds ago
- Qsymia and Lethargy for Women aged 60+ - 6 seconds ago
- Drug interactions of Hydrocortisone Butyrate and Diazepam - 6 seconds ago
- Diabetes Mellitus Inadequate Control and drugs of ingredients of insulin glargine recombinant - 10 seconds ago
- Drug interactions of Lyrica and Olanzapine - 13 seconds ago